Abstract:The newborn infant leaves a germ-free intrauterine environment to enter a contaminated extrauterine world and must have adequate intestinal defences to prevent the expression of clinical gastrointestinal disease states. Although the intestinal mucosal immune system is fully developed after a full-term birth, the actual protective function of the gut requires the microbial stimulation of initial bacterial colonization. Breast milk contains prebiotic oligosaccharides, like inulin-type fructans, which are not digested in the small intestine but enter the colon as intact large carbohydrates that are then fermented by the resident bacteria to produce SCFA. The nature of this fermentation and the consequent pH of the intestinal contents dictate proliferation of specific resident bacteria. For example, breast milk-fed infants with prebiotics present in breast milk produce an increased proliferation of bifidobacteria and lactobacilli (probiotics), whereas formula-fed infants produce more enterococci and enterobacteria. Probiotics, stimulated by prebiotic fermentation, are important to the development and sustainment of intestinal defences. For example, probiotics can stimulate the synthesis and secretion of polymeric IgA, the antibody that coats and protects mucosal surfaces against harmful bacterial invasion. In addition, appropriate colonization with probiotics helps to produce a balanced T helper cell response (Th1=Th2=Th3/Tr1) and prevent an imbalance (Th1>Th2 or Th2>Th1) contributing in part to clinical disease (Th2 imbalance contributes to atopic disease and Th1 imbalance contributes to Crohn's disease and Helicobacter pylori-induced gastritis). Furthermore, a series of pattern recognition receptors, toll-like receptors on gut lymphoid and epithelial cells that interact with bacterial molecular patterns (e.g. endotoxin (lipopolysaccharide), flagellin, etc.), help modulate intestinal innate immunity and an appropriate adaptive immune response. Animal and clinical studies have shown that inulin-type fructans will stimulate an increase in probiotics (commensal bacteria) and these bacteria have been shown to modulate the development and persistence of appropriate mucosal immune responses. However, additional studies are needed to show that prebiotics can directly or indirectly stimulate intestinal host defences. If this can be demonstrated, then prebiotics can be used as a dietary supplement to stimulate a balanced and an appropriately effective mucosal immune system in newborns and infants.

Role of IgA in the Early-Life Establishment of the Gut Microbiota and Immunity: Implications for Constructing a Healthy Start

The Role of Microbiota in Infant Health: from Early Life to Adulthood

Regulation of neonatal IgA production by the maternal microbiota

Secretory IgA: Linking microbes, maternal health, and infant health through human milk

Maternal Immunoglobulin A regulates the development of the neonatal microbiota and intestinal microbiota-specific CD4+ T cell responses

Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health

Sex-Dependent Modulation Of Immune Development In Mice By Secretory Iga-Coated Lactobacillus Reuteri Isolated From Breast Milk

Early life microbiome influences on development of the mucosal innate immune system

Gut microbiota-reactive IgG regulates gut microbiota development and immunity against enteric pathogens in early life

Early-Life Nutrition and Gut Immune Development

IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation

Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression

Dietary regulation of the SIgA-gut microbiota interaction

Breastmilk IgG engages the neonatal immune system to instruct host-microbiota mutualism

Gut dysbiosis during early life: causes, health outcomes, and amelioration via dietary intervention

Probiotics Induce Intestinal IgA Secretion in Weanling Mice Potentially Through Promoting Intestinal APRIL Expression and Modulating the Gut Microbiota Composition.

Intestinal ‘Infant-Type’ Bifidobacteria Mediate Immune System Development in the First 1000 Days of Life

The role of gut-associated lymphoid tissues and mucosal defence

The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals

IgA Dysfunctions Induced by the Early-Lifetime Disruption of Gut Microbitoa Result in Metabolic Syndrome in Mice

Maternal Milk and Fecal Microbes Guide the Spatiotemporal Development of Mucosa-Associated Microbiota and Barrier Function in the Porcine Neonatal Gut